Treatment of Type V dyslipoproteinemia: A rare phenotype of lipid disorders

C.-F Lin,C.-H Liang,J.-Y Chuang,D.-Y Lin,C.-L Tsai,Y.-H Chen,H.-I Yeh,Y.-H Chang

doi:10.1016/j.atherosclerosis.2022.06.426

Treatment of Type V dyslipoproteinemia: A rare phenotype of lipid disorders

C.-F Lin, C.-H Liang + Show 6 more

Open Access

https://doi.org/10.1016/j.atherosclerosis.2022.06.426

Copy DOI

Journal: Atherosclerosis

Publication Date: Aug 1, 2022

Affiliation: Mackay Memorial Hospital, Taipei Medical University

#Phenotype Of Disorders #Tertiary Medical Center + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Background and Aims : Despite Type IV (T4DL) and Type V (T5DL) dyslipidemia are both characterized by hypertriglyceridemia (HTG), T5DL is specifically characterized by a rare phenotype of lipid disorders and the presence of fasting plasma chylomicrons. The present study was aimed to report our experience on treatment of T5DL in a tertiary medical center.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Atherosclerosis

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.